Understanding the use of PARPi combinations to treat patients with mCRPC
15 Sep 2024
Dr Toni Choueiri speaks to ecancer about what to look out for at ASCO GU 2022 in renal.
ASCO GU 2022 is taking place February 17-19 2022 in San Francisco and virtually.
Click here for more information.
Understanding the use of PARPi combinations to treat patients with mCRPC
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Durable responses in aRCC, how do we optimise treatment?
Darolutamide, androgen-deprivation therapy and docetaxel demonstrate promising efficacy mHSPC
EAU 2024: Bladder cancer latest
Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC